The tech world is buzzing with exciting developments and innovations every day, let's find out what's new has been introduced ...

What does 'Last 10' mean? The 'Last 10' information shows this horse's finishing position in its last 10 races. With the most recent on the right. An 'x' signifies a spell and 0 means the horse ...

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 15.7% year on year to $2.91 billion. The company ...

Q4 2024 Management View CEO Reshma Kewalramani highlighted the planned leadership transitions, with Stuart Arbuckle retiring in July 2025. Charlie Wagner will take on additional responsibilities as ...

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals ... And we now know that shaved U.S. Humira sales down to … $7.1 billion. That means Humira still would have been ...

The Food and Drug Administration approved Vertex Pharmaceuticals' non-opioid painkiller pill, a new alternative for pain relief that comes without the risk of addiction. It's a milestone after a ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Vertex estimates that over 80 million people are prescribed a medicine for acute pain every year in the U.S. In the acute setting, William Blair analyst Myles Minter estimates $3.7 billion in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...